Wednesday, July 7, 2021 Daily Archives

Recipharm: $500m fill-finish plant to help Africa gain ‘vaccine sovereignty’

by

Recipharm has signed a Memorandum of Understanding for the fill-finish of biotherapeutics and vaccines in Morocco.    Contract development manufacturing organization (CDMO) Recipharm signed the Memorandum of Understanding (MOU) with the King of Morocco, various Moroccan banks, and the Moroccan Government. As part of the MOU, approximately $500 million will be invested by the Moroccan government and others over the next five years to secure capacity and capability for the production of vaccines and biotherapeutics in Morocco. Recipharm will operate…

July 7, 2021

Exothera selects Pall for suspension-based manufacturing contract

by

Pall will equip Exothera’s expanded facilities in Belgium with a suspension-based manufacturing platform of up to 2,000 L to support the CDMO’s viral vector ambitions. Contract development and manufacturing organization (CDMO) Exothera was launched in March 2020 by Belgium-based bioprocess tech firm Univercells, to offer cell and gene therapy developers process development and viral vector manufacturing. The firm is expanding its two facilities in Jumet, about 25 km south of Brussels, and has selected bioprocess vendor Pall Corporation to equip…

July 7, 2021

Batavia collaborates with Swiss start-up to deliver COVID-19 vaccine

by

Batavia Biosciences will use its HIP-Vax manufacturing technology to develop and deliver 1000 doses of RocketVax’s second generation COVID-19 vaccine candidate.   The deal, of which financial details have not been disclosed, sees Batavia develop the clinical process to deliver RocketVax’s (a subsidiary of Swiss Rockets AG) COVID-19 vaccine candidate RVX-13. RVX-13 does not use a single COVID-19 derived antigen but instead compromises all major immunogenic features of the COVID-19 virus. In turn, this aims to increase vaccine efficacy and…

July 7, 2021